OTC and hyperinsulinemic hypoglycemia, familial, 4: Similarly, tumorigenesis after rAAV injection in mice with mucopolysaccharidosis type VII disease or with ornithine transcarbamylase deficiency was observed (Donsante et al, 2001; Bell et al, 2006), which also suggest that AAV gene therapy needs to be applied in patients without some specific diseases.